Clin Case Rep Int | Volume 6, Issue 1 | Review Article | Open Access

Increasing Incidence of Mucormycosis: A Systemic Review of Case Reports

Kalyanasundaram P, Ramya R, Rajendran K, Nazir Ahamed SB, Mukil Sukitha P and Rajesh Kannan V*

Department of Microbiology, Bharathidasan University, India

*Correspondance to: Rajesh Kannan Velu 

Fulltext PDF

Abstract

There are increasing in reports of mucormycosis in the post COVID-19 patients especially in India. Diabetes mellitus plays a vital role in both severe COVID-19 and mucormycosis. Our aim is to review a literature to find out the patient's characteristics having mucormycosis and COVID-19 with the source of electronic database of Google Scholar and PubMed for the search of review. We have analyzed the data and characteristics of post COVID patients with mucormycosis. Overall, we have collected 288 cases from 50 articles and analyzed. We additionally reviewed why this mucormycosis majorly affects India and mentioned what are all the causes that affect in post- COVID patients. The post-COVID patients with uncontrolled diabetes must be altered and aware with disease mucormycosis.

Keywords:

Diabetes mellitus; Mucormycosis; Post-COVID patients; Electronic database

Citation:

Kalyanasundaram P, Ramya R, Rajendran K, Nazir Ahamed SB, Mukil Sukitha P, Rajesh Kannan V. Increasing Incidence of Mucormycosis: A Systemic Review of Case Reports. Clin Case Rep Int. 2022; 6: 1328.

Subscribe to Our Newsletter